FDA approves nasal glucagon, Baqsimi 06/09/2019 No Comments The U.S. Food and Drug Administration (FDA) has approved Baqsimi (glucagon) nasal powder 3mg for the treatment of severe hypoglycemia in people with diabetes ages Read More ยป